Ads
related to: bipolar diagnosis in adults pdf file template download- BP-I Treatment Info
Find Answers to Common Question
About BP-I Maintenance Treatment
- Starting Treatment
See How This Treatment May Help
Talk to your healthcare provider
- Important Safety Info
See Common Side Effects
For Bipolar I Disorder Treatment
- Patient Resources
View Tools & Resources Available
For Adults With Bipolar I Disorder
- BP-I Treatment Info
m4.havenhealthmgmt.org has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
The Bipolar Spectrum Diagnostic Scale (BSDS) is a psychiatric self-rating scale created by Ronald Pies in screening for bipolar disorder (BD). [1] Its initial version consists of a descriptive narrative aimed to capture the nuances and milder variants of BD. [ 2 ]
Low scores of 5 and below indicate a very low risk of a bipolar diagnosis. High scores of 18 and over indicate a high risk of a diagnosis of bipolar disorder, increasing the likelihood by a factor of seven or greater. [26] [5] Several peer-reviewed research studies support the P-GBI as a reliable and valid measure of bipolar in children and ...
The Eating Disorder Examination Questionnaire (EDE-Q) is a 28-item self-report questionnaire, adapted from the semi-structured interview, the Eating Disorder Examination (EDE). The questionnaire is designed to assess the range, frequency and severity of behaviours associated with a diagnosis of an eating disorder.
One meta-analysis of bipolar disorder in young people worldwide estimated that about 1.8% of people between the ages of seven and 21 have bipolar disorder. [127] Similar to adults, bipolar disorder in children and adolescents is thought to occur at a similar frequency in boys and girls. [127]
The global estimated lifetime prevalence of bipolar disorder among adults range from 1 to 3 percent. [63] The annual incidence is estimated to vary from 0.3 to 1.2 percent worldwide. [ 23 ] According to the World Mental Health Survey Initiative, the lifetime prevalence of BP-II was found to be 0.4%, with a 12-month prevalence of 0.3%. [ 64 ]
The MDQ was developed as a screening tool for bipolar disorder, and assesses symptoms of mania and hypomania [6] It was developed in the hopes that it would reduce the mis-diagnosis and delayed diagnosis of bipolar disorder. [6] The first 13 items on the measure ask about any manic/hypomanic symptoms that may have occurred during one's lifetime ...